News
Veranex, a global provider of product development and contract research services, today introduced the industry’s first ...
Johnson & Johnson (NYSE:JNJ) is set to kick off the second quarter pharma earnings on Wednesday, with investors focusing on ...
Despite healthcare spending cuts, medtech stocks like Edwards Life Sciences, Stryker, and Boston Scientific are rising, ...
The year kicked off with a handful of acquisitions from top companies. Dealmaking has since slowed amid economic uncertainty ...
Proximie (the "Company"), the leading global health technology platform digitising operating rooms ("OR"), announces a ...
Johnson & Johnson MedTech today announced FDA approval for an update to its Varipulse platform's irrigation flow rate.
Clinical trials are the last piece of the puzzle for Ireland’s medtech sector, says University of Galway’s John Kilmartin.
One Six 8 Ventures’ Judyanna Yu explains why capital alone isn’t enough to scale life sciences companies at home.
Medical technology has been on the up for many years, and professionals and experts in Australia have been making strides in innovation over the last decade.
Reviewing its MedTech coverage ahead of the Q2 earnings season on Tuesday, Morgan Stanley upgraded Steris (NYSE:STE) and Solventum (NYSE:SOLV) to Overweight from Equal Weight and downgraded RxSight ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback